LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Autor: | M. Li, Kaoru Kondo, Ming Lei, T. Liu, Lucjan Wyrwicz, Michael Schenker, Marcelo Garrido, Tomasz Skoczylas, L. Shen, Jaffer A. Ajani, Yelena Y. Janjigian, Valerie Poulart, A. Campos Bragagnoli, Markus Moehler, Dana Cullen, K. Shitara, Kensei Yamaguchi, Mustapha Tehfe, Pamela Salman, Patricio Eduardo Yanez |
---|---|
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Annals of Oncology. 31:S1191 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |